Author

S. Artham

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1

Frequent Co-Authors

D. Mukherjee· 3 shared D. P. McDonnell· 3 shared C.-Y. Chang· 2 shared J. Byemerwa· 2 shared P. K. Juras· 2 shared A. D. Nguyen· 1 shared B. Chakraborty· 1 shared C. D. Baeta· 1 shared

Activity by Year

2022-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

D. Mukherjee

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

UDP-6-glucose dehydrogenase in hormonally responsive breast cancers

M. J. Price, A. D. Nguyen, C. Haines, C. D. Baeta, J. Byemerwa, D. Mukherjee, S. Artham, V. Kumar, C. Lavau, S. Wardell, S. Varghese, C. R. Goodwin

This study shows that UGDH knockdown reduces estrogen-induced tumorigenic traits in breast cancer models and validates findings in human clinical specimens.

bioRxiv · Mar 20, 2024 · PreprintCancer Biology

Ca2+/Calmodulin Dependent Protein Kinase Kinase-2 (CaMKK2) promotes Protein Kinase G (PKG)-dependent actin cytoskeletal assembly to increase tumor metastasis

D. Mukherjee, R. A. Previs, C. N. Haines, M. Al Abo, P. K. Juras, K. C. Strickland, B. Chakraborty, S. Artham, R. Whitaker, K. L. Hebert, J. Fontenot, S. R. Patierno, J. A. Freedman, F. H. Lau, M. Burow, , D. P. McDonnell

This study identifies CaMKK2 as a driver of tumor metastasis through a novel signaling pathway involving PDE1A, PKG1, and VASP, suggesting it as a therapeutic target for TNBC and HGSOC.

bioRxiv · Apr 17, 2023 · PreprintCancer Biology

Increased CaMKK2 expression is an adaptive response that maintains the fitness of tumor-infiltrating natural killer cells

P. K. Juras, L. Racioppi, D. Mukherjee, S. Artham, X. Gao, L. A. D'Agostino, C.-Y. Chang, D. P. McDonnell

This study shows that CaMKK2 in tumor-infiltrating NK cells suppresses apoptosis and promotes proliferation, with its expression driven by intracellular lactic acid.

bioRxiv · May 18, 2022Cancer Biology

A new chemotype of chemically tractable nonsteroidal estrogens based on a thienopyrimidine core.

V. R. Sammeta, J. D. Norris, S. Artham, C. D. Torrice, J. Byemerwa, C. Joiner, S. W. Fanning, D. P. McDonnell, T. M. Willson

The paper identifies a new chemotype of nonsteroidal estrogens based on a thienopyrimidine core through targeted screening and structure-guided optimization.

bioRxiv · Apr 15, 2022Cell Biology